ABVACC, INC.
Enabling next generation vaccines and immunotherapeutics by rational design
ROCKVILLE, United States · Founded 2021 · $597K raised
- Headquarters
- ROCKVILLE, Maryland
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- abvacc.com
- Total Funding
- $597K
- Last Round
- $597K GrantFeb 2024
About
AbVacc is a biotechnology company focused on structure-guided design of novel vaccines and therapeutics for emerging infectious diseases, including bacterial infections (S. aureus) and viral threats (Ebola, Marburg, Nipah). The company's pipeline includes IBT-V02, a vaccine for prevention of recurrent staphylococcal skin infections, as well as potently neutralizing antibody therapeutics. AbVacc collaborates with NIAID/NIH, the National Cancer Institute, USAMRIID, and the Department of Defense.
Summary
ABVACC, INC. is a Biotech company based in ROCKVILLE, United States, founded in 2021. It has raised $597K in total, most recently a $597K Grant round in Feb 2024.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.